COCs appeared to significantly reduce symptoms of dysmenorrhea in PD and SD, but insufficient data exist to compare the effectiveness of COCs to NSAIDs, TCM, GnRH agonists, and LNG-IUS. This evidence concerns the gene GNRH1 and Salla disease.